Literature DB >> 34244054

The estimated burden of 15 vaccine-preventable diseases from 2008 to 2020 in Japan: A transition by the COVID-19 pandemic.

Taito Kitano1.   

Abstract

BACKGROUND: Evaluating the national burdens across multiple vaccine-preventable diseases (VPDs) can be informative to identify the areas for improvements in the national immunization program.
METHODS: The annual burden of diseases from 2008 to 2020 in Japan were calculated with the incidence- and pathogen-based approach for the 15 VPDs (hepatitis B virus infection, human papillomavirus (HPV), influenza, invasive pneumococcal disease, invasive Haemophilus influenzae type b (Hib) disease, invasive meningococcal disease, Japanese encephalitis, measles, mumps, pertussis, rotavirus, rubella, tetanus, tuberculosis and varicella), using disability-adjusted life year (DALY).
RESULTS: The average annual burden between 2008 and 2020 is the highest in influenza (114,129 DALY/year), followed by HPV infection, hepatitis B virus infection, tuberculosis and mumps (109,782, 69,883, 23,855 and 5693 DALY/year). In the pre-COVID-19 period (2008-2019), the decreasing trend of burden was observed in hepatitis B virus infection, invasive pneumococcal disease, invasive Hib disease, tuberculosis and varicella. HPV infection is the only VPD which had more than 100,000 DALY/year for all years during the study period. In 2020, the estimated annual burdens are decreased in influenza (71%), invasive pneumococcal disease (51%), invasive Hib diseases (54%), invasive meningococcal disease (64%), measles (98%), mumps (47%) pertussis (83%), rotavirus infection (95%), rubella (94%) and varicella (35%) compared with those in 2019.
CONCLUSIONS: The study demonstrated decreasing trends of burdens for some VPDs, while a persistently high burden has been observed for other VPDs, including HPV infection. The COVID-19 pandemic has caused dramatic reductions in the burdens of many VPDs in 2020.
Copyright © 2021. Published by Elsevier Ltd.

Entities:  

Keywords:  Burden; COVID-19; Disability-adjusted life years; Human papillomavirus; Influenza; Vaccine

Year:  2021        PMID: 34244054     DOI: 10.1016/j.jiac.2021.06.021

Source DB:  PubMed          Journal:  J Infect Chemother        ISSN: 1341-321X            Impact factor:   2.211


  3 in total

1.  Population-based study of influenza and invasive meningococcal disease among Greek children during the COVID-19 pandemic.

Authors:  Theoklis Zaoutis; Vassiliki Papaevangelou; Danai Ktena; Eleni Kourkouni; Flora Kontopidou; Kassiani Gkolfinopoulou; Kalliopi Papadima; Theano Georgakopoulou; Ioanna Magaziotou; Anastasia Andreopoulou; Georgina Tzanakaki
Journal:  BMJ Paediatr Open       Date:  2022-03

2.  The Impact of COVID-19 on Outpatient Antibiotic Prescriptions in Ontario, Canada; An Interrupted Time Series Analysis.

Authors:  Taito Kitano; Kevin A Brown; Nick Daneman; Derek R MacFadden; Bradley J Langford; Valerie Leung; Miranda So; Elizabeth Leung; Lori Burrows; Douglas Manuel; Dawn M E Bowdish; Colleen J Maxwell; Susan E Bronskill; James I Brooks; Kevin L Schwartz
Journal:  Open Forum Infect Dis       Date:  2021-10-30       Impact factor: 3.835

3.  Measles Vaccination and Outbreaks in Croatia from 2001 to 2019; A Comparative Study to Other European Countries.

Authors:  Ines Drenjančević; Senka Samardžić; Ana Stupin; Katalin Borocz; Peter Nemeth; Timea Berki
Journal:  Int J Environ Res Public Health       Date:  2022-03-31       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.